View Older Stories View More Recent Stories

Oct 21, 2020 10:15AM RA Capital Management, LP Closes its Second Venture Capital Fund, Raising $461 Million

Oct 14, 2020 06:00AM Nimbus Therapeutics Announces $60 Million Private Financing From New Investors to Advance Expanded Pipeline

Oct 9, 2020 04:30PM Form SC 13G Cardiff Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Oct 7, 2020 05:00PM Form SC 13D/A Eidos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Oct 1, 2020 09:00AM Olema Oncology Raises $85 Million in Series C Financing to Advance Clinical Development of OP-1250 in Breast Cancer

Sep 21, 2020 05:25PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Sep 16, 2020 08:52PM Form 3 Dyne Therapeutics, Inc. For: Sep 16 Filed by: RA CAPITAL MANAGEMENT, L.P.

Sep 14, 2020 07:00AM Colorescience® Announces Successful Completion of $30 Million Debt Financing

Sep 10, 2020 04:30PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.

Aug 27, 2020 02:00AM Saniona publishes its interim report for the second quarter 2020

Aug 26, 2020 09:00AM Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand

Aug 26, 2020 07:30AM Kinnate Biopharma Closes $98 Million Series C Financing

Aug 26, 2020 07:00AM Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

Aug 24, 2020 08:00AM Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

Aug 18, 2020 08:30PM Form 3 Inhibrx, Inc. For: Aug 18 Filed by: RA CAPITAL MANAGEMENT, L.P.

Aug 14, 2020 04:25PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30

Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Aug 11, 2020 07:00AM Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results

Aug 10, 2020 04:02PM Novavax Reports Second Quarter 2020 Financial and Operational Results

Aug 10, 2020 01:00AM Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares

Aug 6, 2020 09:40AM Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding for Potential Disease-Modifying Pulmonary Arterial Hypertension Therapy

Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

Aug 6, 2020 05:30AM T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

Aug 5, 2020 04:30PM Form SC 13D iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Aug 5, 2020 07:00AM GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimm

Aug 3, 2020 08:00AM PMV Pharma Closes $70 Million in Series D Financing

Jul 30, 2020 07:17AM Cerevel Therapeutics and SPAC Arya Sciences Acquisition Corp II (ARYBU) Announce Business Combination

Jul 30, 2020 07:00AM  Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development

Jul 29, 2020 09:36PM Form 4 iTeos Therapeutics, Inc. For: Jul 28 Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 29, 2020 09:00AM Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish

Jul 24, 2020 04:34PM Form SC 13D Nkarta, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 23, 2020 09:00PM Form 3 Inozyme Pharma, Inc. For: Jul 23 Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 22, 2020 08:00AM Olema Oncology Announces $54 Million Series B Financing

Jul 17, 2020 07:55AM Verona Pharma plc (VRNA) Raises $200 Million in Oversubscribed Private Placement and Subscription

Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription

Jul 17, 2020 02:00AM Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription

Jul 16, 2020 08:52PM Form 3 Pandion Therapeutics, For: Jul 16 Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 13, 2020 02:21PM Vaxart (VXRT) Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility (Earlier)

Jul 13, 2020 01:34PM Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility

Jul 10, 2020 04:34PM Form SC 13G Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 10, 2020 04:30PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 10, 2020 04:25PM Form SC 13G/A Verastem, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 10, 2020 04:15PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public Offering, Including the Full Exercise of the Underwriter’s Option To Purc

Jul 9, 2020 08:58PM Form 3 Nkarta, Inc. For: Jul 09 Filed by: RA CAPITAL MANAGEMENT, L.P.

Jul 8, 2020 12:38PM Therapeutics Acquisition Corp. (TXAC) Prices 11.8M Class A Share IPO at $10/Sh

Jul 8, 2020 12:25PM Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering

Jul 7, 2020 07:00AM Vor Biopharma Closes $110 Million Series B Financing

Jul 1, 2020 08:30AM Bolt Biotherapeutics Closes $93.5 Million Series C Financing

Jun 26, 2020 12:00AM Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer

View More Recent Stories View Older Stories